Global Over-The-Wire Micro-Guide Catheter Market Overview
The Over The Wire Micro Guide Catheter Market Size was valued at USD 1.32 Billion in 2023. The Global Over The Wire Micro Guide Catheter industry is projected to grow from USD 1.67 Billion in 2024 to USD 2.45 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.67% during the forecast period (2024 - 2032). Over-the-wire micro-guide catheters are in-vitro tests that use antigen-antibody reaction to detect the concentrations of a wide range of biological substances in the blood and other fluids. Over-the-wire micro-guide catheters are extensively used in several areas of pharmaceutical research such as therapeutic drug monitoring, disease diagnosis, clinical pharmacokinetics, and bioequivalence studies in drug discovery, among others.
Growing preference towards minimally invasive surgical procedures, technological advancements in over-the-wire micro-guide catheters, an increasing number of patients suffering from cardiac and neurovascular disorders, rising geriatric population are the major drivers propelling market growth. However, the risk of infections, lack of skilled physicians may constrain the growth of the market.
In February 2024, BIOTRONIK is delighted to introduce the Micro Rx™ catheter, an innovative rapid exchange microcatheter that has been designed to simplify the process of improving guidewire support during percutaneous coronary interventions (PCI). This innovative device, which is exclusively distributed by BIOTRONIK, is produced by IMDS (Interventional Medical Device Solutions). The Micro Rx catheter is the fourth IMDS product that BIOTRONIK has introduced to the United States, resulting in a compelling portfolio of devices that includes NHancer Rx, TrapIT, and ReCross catheters. The Micro Rx catheter is equipped with a reinforced distal shaft that is constructed with a core wire sandwiched between two layers of braids to facilitate optimal push transfer. Additionally, it has a tapered tip with the tiniest leading edge on the market, which provides increased penetration force. Furthermore, it is equipped with a Proximal-End-Stop that has been meticulously designed to facilitate the seamless integration of a guide extension catheter2 to augment its support. The Micro Rx catheter is engineered to prioritize user-friendly intervention, thereby eliminating the necessity for trapping, in recognition of the complexities associated with traversing through challenging vascular anatomies, such as highly stenosed lesions and tortuous vessels. The objective of this method is to reduce the risk of vascular trauma during procedures, thereby reducing the duration of patients' exposure to the catheterization lab environment and the associated risks. It has the capacity to facilitate the successful treatment of more intricate anatomies by non-chronic total occlusion (CTO) operators.
In April 2022, Transit Scientific announced that its XO Cross Support Catheter Platform had been cleared by the FDA for coronary use. The platform is intended to facilitate the exchange of wires, guide and support a guidewire during access to the peripheral or coronary vasculature, and provide a conduit for the delivery of saline solutions or diagnostic contrast agents. Support catheters are employed to assist in the navigation of guidewires through intricate lesions and to facilitate guidewire exchanges during interventional procedures in patients with peripheral or coronary artery disease. Legacy technologies frequently fail to provide adequate guidewire support, are susceptible to kinking, and lack the pushability necessary to effectively navigate severe calcifications and plaque. The XO Cross Support Catheter platform is engineered to provide unprecedented levels of torque response, flexibility, trackability, and pushability, thereby facilitating access to tortuosity and challenging lesions. The non-tapered metal-alloy and polymer construction provides outstanding fatigue resistance against the challenging, intricate lesions that are present in advanced coronary artery disease (CAD), peripheral artery disease (PAD), and critical limb ischemia (CLI).
Over-The-Wire Micro-Guide Catheter Market Trends
Growing preference for minimally invasive surgical procedures. For instance, according to the American Heart Association and Stroke Statistics (2017), about 92.1 million American adults are living with cardiovascular diseases and strokes, and cardiovascular diseases are the significant causes of death globally which accounted for 17.9 million deaths per year in 2015. The number is expected to reach more than 23.6 million by 2030. Additionally, technological advancements in over-the-wire micro-guide catheters, an increasing number of patients suffering from cardiac and neurovascular disorders, and increasing geriatric population are likely to support market growth. On the other hand, risk of infections, lack of skilled physicians is anticipated to hamper the market growth.
Over-The-Wire Micro-Guide Catheter Market Segment Insights
The over-the-wire micro-guide catheter market has been segmented into application and end user.
Over-The-Wire Micro-Guide Catheter Application Insights
Based on application, the market has been segmented into cardiovascular, neurovascular, and others. The cardiovascular segment has been further bifurcated into angiography, angioplasty, peripheral stenting, and others. The neurovascular segment has been further segmented into intracranial aneurysms, percutaneous neuro-interventional procedures, and others.
Over-The-Wire Micro-Guide Catheter End User Insights
By end user, the market has been segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others. The cardiovascular segment accounted for a market value of USD 59.60 million in 2017.
Over-The-Wire Micro-Guide Catheter Regional Insights
The over-the-wire micro-guide catheter market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to be the most significant over-the-wire micro-guide catheter market during the forecast period. This is attributed to the increasing occurrences of coronary heart diseases, neurovascular diseases, hypertension, and other metabolic disorders, raising awareness for health, advancement in technologies, good healthcare infrastructure, and favorable reimbursement policies. The European market for the over-the-wire micro-guide catheter is expected to be the second-largest during the forecast period. This can attribute to the rising occurrences of cardiovascular and neurovascular diseases in the geriatric population, government initiatives to boost up clinical research and development, preference of minimally invasive surgery,
Asia-Pacific is estimated to be the fastest-growing market due to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and, favorable health insurance and reimbursement policies drive the over-the-wire micro-guide catheter market. Moreover, in the Asia-Pacific region, China accounted for a market share of 20.20% in 2017. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to lack of proper healthcare infrastructure, unaffordability of high-cost surgeries, and lack of skilled healthcare professionals
Key Players
The prominent players in the over-the-wire micro-guide catheter market are
Some of the key strategies followed by the players operating in the over-the-wire micro-guide catheter market were continuous innovation and development of the new and better products to beat the opponents and strive in this big market.
Recent Development
In May 2016, Merit Medical Systems signed a distribution deal with PIOLAX Medical Devices, Inc., Japan for a product known as Labyrinth Noah Micro Guide Wire in Japan. With this collaboration, Merit Medical became a global distributor (excluding Japan) of micro-guide wiresInAugust 2017, Koninklijke Philips NV completed the acquisition of The Spectranetics Corporation, which had a considerable market in vascular intervention.InOctober 2017, Teleflex acquired NeoTract, Inc. (NeoTract), a medical device company that has developed and commercialized the UroLift System, a minimally invasive medical device for treating lower urinary tract symptoms due to benign prostatic hyperplasia or BPH.
Over-The-Wire Micro-Guide Catheter Market Segmentation
Over-the-Wire Micro-Guide Catheter Application Outlook
- Cardiovascular
- Angiography
- Angioplasty
- Peripheral Stenting
- Others
- Neurovascular
- Intracranial Aneurysms
- Percutaneous Neuro interventional Procedures
- Others
- Others
Over-the-Wire Micro-Guide Catheter End User Outlook
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Research & Academic Institutes
- Others
Over-the-Wire Micro-Guide Catheter Regional Outlook
- Americas
- North America
- South America
- Europe
- Western Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Available Additional Customizations
Over-the-Wire Micro-Guide Catheter Market segment by Type
Intended Audience
- Medical device manufacturers and distributors
- Government research organizations
- Hospitals and clinics
- Regulatory agencies
- Pharmaceutical companies
|
Report Attribute/Metric
|
Details
|
|
Market Size 2032
|
USD 2.45 Billion
|
|
Compound Annual Growth Rate (CAGR)
|
11.67%(2024-2032)
|
|
Base Year
|
2023
|
|
Market Forecast Period
|
2024-2032
|
|
Historical Data
|
2018 & 2020
|
|
Market Forecast Units
|
Value (USD Billion)
|
|
Report Coverage
|
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
|
|
Segments Covered
|
Application, End User, Region
|
|
Geographies Covered
|
North America, Europe, Asia Pacific, and Rest of the World
|
|
Countries Covered
|
The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
|
|
Key Companies Profiled
|
Terumo Corporation, Medtronic, Boston Scientific Corporation, Koninklijke Philips NV, Teleflex.
|
|
Key Market Opportunities
|
Growing preference towards minimally invasive surgical procedures
|
|
Key Market Drivers
|
Increasing Prevalence of Cardiovascular Diseases
Increased awareness and government initiatives
|
Over-the-wire Micro-Guide Catheter Market Highlights:
Frequently Asked Questions (FAQ) :
over-the-wire micro-guide catheter market projected to grow at approximately 11.67% CAGR during the assessment period (2024-2032).
The valuation of the global over-the-wire micro-guide catheter market is estimated to increase to USD 2.45 Billion by the end of 2032.
Increasing occurrences of neurovascular diseases, coronary heart diseases, hypertension, and other metabolic disorders and rising awareness for health are major tailwinds pushing the growth of the global over-the-wire micro-guide catheter market.
North America holds the largest share in the global over-the-wire micro-guide catheter market, followed by Europe and the Asia Pacific, respectively.
Cardinal Health, Enki – Microtubes, DePuy Synthes, Penumbra Inc., Koninklijke Philips N.V, Terumo Europe N.V., Merit Medical Systems Inc., Integer Holdings Corporation, Teleflex Incorporated, Boston Scientific Corporation, Cook Medical, Medtronic plc., and Asahi Intecc Company Limited, are some of the top players operating in the global over-the-wire micro-guide catheter market.
